Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by First Trust Advisors LP

First Trust Advisors LP boosted its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 108.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,144 shares of the company's stock after buying an additional 15,167 shares during the period. First Trust Advisors LP owned approximately 0.16% of Addus HomeCare worth $3,653,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its holdings in shares of Addus HomeCare by 10.2% during the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock worth $24,371,000 after purchasing an additional 16,997 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after buying an additional 75,409 shares during the last quarter. Cherry Creek Investment Advisors Inc. purchased a new position in Addus HomeCare during the fourth quarter valued at approximately $340,000. Amundi raised its position in Addus HomeCare by 185.9% during the fourth quarter. Amundi now owns 9,008 shares of the company's stock valued at $1,139,000 after acquiring an additional 5,857 shares in the last quarter. Finally, Barclays PLC boosted its position in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after purchasing an additional 29,207 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS traded up $4.69 during midday trading on Tuesday, hitting $109.06. The company's stock had a trading volume of 392,874 shares, compared to its average volume of 164,782. Addus HomeCare Co. has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a market cap of $2.01 billion, a P/E ratio of 24.96, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The business's 50 day simple moving average is $97.64 and its 200 day simple moving average is $114.80.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same period in the previous year, the firm posted $1.21 EPS. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ADUS has been the subject of a number of recent analyst reports. Stephens reaffirmed an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer boosted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Macquarie restated an "outperform" rating and set a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. Finally, StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare has a consensus rating of "Buy" and a consensus target price of $139.00.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.